State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| 1 |
Capital One
COF
|
+$2.29B |
| 2 |
Microsoft
MSFT
|
+$1.57B |
| 3 |
NVIDIA
NVDA
|
+$1.51B |
| 4 |
Coinbase
COIN
|
+$1.49B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.22B |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.87B |
| 2 |
Exxon Mobil
XOM
|
+$662M |
| 3 |
Chevron
CVX
|
+$653M |
| 4 |
JPMorgan Chase
JPM
|
+$647M |
| 5 |
Morgan Stanley
MS
|
+$426M |
Sector Composition
| 1 | Technology | 30.34% |
| 2 | Financials | 14.16% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Healthcare | 9.64% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Inhibikase Therapeutics
IKT
$125M
| $776K | ﹤0.01% |
397,812
+355,928
| +850% | +$694K |
|
3352
HireQuest
HQI
$145M
| $774K | ﹤0.01% |
77,359
+1,611
| +2% | +$16.1K |
|
3353
Lexicon Pharmaceuticals
LXRX
$403M
| $774K | ﹤0.01% |
818,621
-1,788,953
| -69% | -$1.69M |
|
3354
Hanover Bancorp
HNVR
$163M
| $773K | ﹤0.01% |
+33,786
| New | +$773K |
|
3355
Lineage Cell Therapeutics
LCTX
$295M
| $771K | ﹤0.01% |
849,522
-1,800,664
| -68% | -$1.63M |
|
3356
Sagimet Biosciences
SGMT
$229M
| $760K | ﹤0.01% |
99,800
| – | – |
|
3357
Prairie Operating Co
PROP
$115M
| $759K | ﹤0.01% |
253,299
+151,658
| +149% | +$454K |
|
3358
Greenwich LifeSciences
GLSI
$156M
| $746K | ﹤0.01% |
82,247
+7,039
| +9% | +$63.8K |
|
3359
Myomo
MYO
$34M
| $738K | ﹤0.01% |
341,825
+246,850
| +260% | +$533K |
|
3360
Mercer International
MERC
$209M
| $734K | ﹤0.01% |
205,213
+11,400
| +6% | +$40.8K |
|
3361
SWK Holdings
SWKH
$177M
| $732K | ﹤0.01% |
49,657
-11,243
| -18% | -$166K |
|
3362
Geospace Technologies
GEOS
$212M
| $730K | ﹤0.01% |
51,189
-107,427
| -68% | -$1.53M |
|
|
ONL
3363
Orion Office REIT
ONL
$166M
| $727K | ﹤0.01% |
338,120
-997,499
| -75% | -$2.14M |
|
3364
ORIX
IX
$30.2B
| $724K | ﹤0.01% |
32,135
| – | – |
|
3365
Lucid Diagnostics
LUCD
$109M
| $717K | ﹤0.01% |
623,068
+578,087
| +1,285% | +$665K |
|
|
BZAI
3366
Blaize Holdings, Inc. Common Stock
BZAI
$336M
| $716K | ﹤0.01% |
240,270
+158,120
| +192% | +$471K |
|
|
AVR
3367
Anteris Technologies Global Corp. Common Stock
AVR
$180M
| $715K | ﹤0.01% |
188,715
+99,911
| +113% | +$379K |
|
3368
Nice
NICE
$8.81B
| $701K | ﹤0.01% |
4,148
| – | – |
|
3369
Structure Therapeutics
GPCR
$1.2B
| $694K | ﹤0.01% |
33,459
+22,719
| +212% | +$471K |
|
3370
Alpha Teknova
TKNO
$239M
| $688K | ﹤0.01% |
140,107
+71,462
| +104% | +$351K |
|
3371
Betterware México
BWMX
$508M
| $687K | ﹤0.01% |
79,394
+1,792
| +2% | +$15.5K |
|
|
DFDV
3372
DeFi Development Corp. Common Stock
DFDV
$406M
| $684K | ﹤0.01% |
+31,920
| New | +$684K |
|
3373
Perma-Pipe International
PPIH
$254M
| $674K | ﹤0.01% |
29,468
| – | – |
|
3374
Lightwave Logic
LWLG
$397M
| $674K | ﹤0.01% |
543,269
-1,938,279
| -78% | -$2.4M |
|
3375
Abacus Life
ABL
$619M
| $668K | ﹤0.01% |
129,930
+55,230
| +74% | +$284K |
|